| Date | Title | Description |
| 06.01.2026 | Moray Wright features in Professional Adviser | For more than three decades, the Enterprise Investment Scheme has played a significant role in backing founders across the UK. With its expansion at the Budget, it is now positioned to support a far greater number of businesses to scale, no... |
| 05.09.2025 | Netomnia secures €346.2M, 0TO9's plan to build 1,000 fintechs by 2045, and August tech funding cooldown | This week, we tracked more than 60 tech funding deals worth over €1.3 billion, and over 25 exits, M&A transactions, rumours, and related news stories across Europe. In addition to this week's top financials, we've also indexed the most ... |
| 02.09.2025 | SeqOne Acquires Congenica | SeqOne, a Montpellier, France-based AI-driven genomic analysis company, acquired Congenica, a Cambridge, UK-based digital health company.
The amount of the deal was not disclosed.
The combined entity will have expanded global footprint:
Ena... |
| 02.09.2025 | SeqOne acquires Congenica to create a global leader in AI-powered genomic medicine | Strategic acquisition of UK genomics leader Congenica reinforces SeqOne market position and footprint - servicing over 160 labs in 30+ countries ROME, ITALY, September 2, 2025 /EINPresswire.com/ -- SeqOne, a pioneer in AI-driven genomic ana... |
| 02.09.2025 | SeqOne acquires Congenica to create a global leader in AI-powered genomic medicine | SeqOne, a pioneer in AI-driven genomic analysis, has entered into a definitive agreement to acquire Congenica, the UK company spun out of the Wellcome Sanger Institute. The acquisition creates the largest global ‘software pure player’ in th... |
| 02.09.2025 | Dcluttr Raises Pre-Seed Funding Round | Dcluttr, a Bengaluru, Karnataka, India-based AI copilot for growth marketing, raised an undisclosed amount in Pre-Seed funding.
The round was led by Campus Fund.
The company intends to use the funds for technology development, product desig... |
| 02.09.2025 | Montpellier-based SeqOne acquires Cambridge-based Congenica to create a global leader in AI-powered genomic medicine | SeqOne, a French innovator in AI-driven genomic analysis, today announced it has entered into a definitive agreement to acquire Congenica, the UK company spun out of the Wellcome Sanger Institute.
The acquisition is set to create the “large... |
| 03.05.2025 | What is a Knowledge Intensive company? | Knowledge intensive companies are important because they fuel innovation, help develop new technologies and tend to lead to economic growth. Many of these companies have a unique approach to creating value, primarily through intellectual ex... |
| 30.12.2024 | Growth Investor of the Year 2024 Winner | We are delighted to announce that Parkwalk was announced Growth Investor of the Year at the 2024 Growth Investor Awards! It was a fantastic event celebrating the incredible achievements of companies and individuals driving innovation and gr... |
| 07.05.2024 | Parkwalk – EIS explained: what is the Enterprise Investment Scheme?
Conclusion | The Enterprise Investment Scheme (EIS) is a useful tax planning tool for investors to take advantage of 5 generous tax benefits*, as well as investing in some of the brightest minds and world-changing innovations in the UK. Our CEO, Moray W... |
| 21.03.2023 | Parkwalk – Improving Healthcare by Investing in Genomics | To mark the end of Healthcare Science Week, we discuss the value and impact of investing in genomics. We also give examples of some ground-breaking genomic companies Parkwalk has invested in. |
| 06.12.2022 | Congenica awarded European contract to develop NGS analysis workflow in oncology | Congenica awarded European contract to develop NGS analysis workflow in oncology
Congenica, a UK-based digital health company that enables the rapid analysis and interpretation of genomic data, has been awarded the second stage of a contrac... |
| 11.08.2022 | Congenica announces partnership with Avesthagen | Congenica announces partnership with Avesthagen
New deal strengthens Congenica’s presence in India
Congenica, a digital health company that enables precision medicine through its world-leading diagnostic decision support platform for genomi... |
| 04.08.2022 | Collaborative development of novel Precision Oncology Solution | Collaborative development of novel Precision Oncology Solution
Congenica, a UK-based digital health company that enables the rapid analysis and interpretation of genomic data, has selected the GenomOncology Precision Oncology Platform for t... |
| 01.02.2022 | Congenica 3.3 improves genomic data analysis and automates workflow | Congenica 3.3 improves genomic data analysis and automates workflow
Data interpretation is by far the most time-consuming and resource-intensive step of the NGS workflow. Any time savings that can be found have a significant impact on overa... |
| 23.11.2021 | The Cambridge cluster’s success - people united behind the common goal of fuelling purpose-driven innovation | The secret to the Cambridge cluster’s success - people united behind the common goal of fuelling purpose-driven innovation
By Andrew Williamson | Managing Partner, Cambridge Innovation Capital
On Monday 1st November, we were privileged to h... |
| 21.09.2021 | Congenica is Joint Winner of MIT Solve The Horizon Prize | Congenica is Joint Winner of MIT Solve The Horizon Prize
Award recognises the role of Congenica’s artificial intelligence initiative in using data to help rare disease patients get the right care faster and more accurately
Congenica, the di... |
| 19.08.2021 | Congenica signs distribution agreement with ATC Healthcare in Turkey | Congenica signs distribution agreement with ATC Healthcare in Turkey
Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, today announces a new distribution agreemen... |
| 21.07.2021 | Congenica receives CE Mark for genomic analysis software | Congenica receives CE Mark for genomic analysis software
Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, today announces that its genomic interpretation softwar... |
| 17.06.2021 | Gene mapping will reduce fatal drug interactions in older people | Gene mapping will reduce fatal drug interactions in older people
New software will help reduce adverse drug reactions thanks to a joint investment of £2 million from UK Research and Innovation (UKRI) and Legal & General.
Announcement by... |
| 06.04.2021 | Congenica appoints Jayesh Pankhania as Chief Financial Officer | Congenica appoints Jayesh Pankhania as Chief Financial Officer
Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, is pleased to announce the appointment of Jayesh ... |
| 31.03.2021 | Institute of Immunology and Genetics in Kaiserslautern selects Congenica to accelerate its whole exome sequencing | Institute of Immunology and Genetics in Kaiserslautern selects Congenica to accelerate its whole exome sequencing
Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives... |
| 15.03.2021 | Congenica signs distribution agreement with AmpliTech in France | Congenica signs distribution agreement with AmpliTech in France
AmpliTech to distribute Congenica's world-leading NGS data analysis and clinical decision support software in France
Congenica, the digital health company enabling rapid and ac... |
| 11.03.2021 | Seeding a Life-Changing International Genomic Insight Alliance to Treat Pediatric Epilepsy, Upcoming Webinar Hosted by Xtalks | One-third of patients are non-responsive to existing treatments which necessitates the need for further understanding of the genetics and biology that cause some types of epilepsy.
TORONTO (PRWEB) March 11, 2021
It is estimated that over 50... |
| 04.03.2021 | Congenica’s £39M Series C funding: QVentures invests in Britain’s fastest-growing genomics startup | London-based venture capital firm, QVentures announces to have backed Britain’s fastest-growing genomics company, Congenica’s Series C round of funding. QVenture’s investment follows an initial round of investment in November 2020.
In the m... |
| 01.03.2021 | Congenica appoints Kamraan Shariff as Chief Business Development Officer | Congenica appoints Kamraan Shariff as Chief Business Development Officer
Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, today announces the appointment of Kamr... |
| 19.02.2021 | David Atkins, CEO of Congenica, has joined the National Genomics Board | Dr David Atkins, Chief Executive Officer of Congenica, has joined the National Genomics Board as the BioIndustry Association (BIA)’s SME representative.
The Board brings together senior decision makers from government, the NHS, academia and... |
| 03.02.2021 | Congenica enters cancer collaboration with Gabriel Precision Oncology | Congenica enters cancer collaboration with University of Glasgow spinout Gabriel Precision Oncology
Agreement with Gabriel Precision Oncology to support the routine use of advanced cancer genomics in healthcare
Congenica, the digital health... |
| 27.01.2021 | A year in review: Business update January 2021 | Cambridge has always been at the forefront of innovation. As the leading venture capital investor in Cambridge, CIC plays a central role in commercialising this innovation for the benefit of society. In the last year, CIC’s existing portfol... |
| 14.01.2021 | Congenica launches Patient Advocacy and Engagement Advisory Board | Congenica launches Patient Advocacy and Engagement Advisory Board
14-01-2021
Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, announces the launch of a Patient A... |
| 14.01.2021 | Congenica launches Patient Advocacy and Engagement Advisory Board | Congenica launches Patient Advocacy and Engagement Advisory Board
Leading advocacy professionals to ensure patient remains central to Congenica’s approach
Congenica, the digital health company enabling rapid and accurate analysis of complex... |
| 07.12.2020 | Congenica inclusion in AJHG “Year in Review” 2020 | Congenica inclusion in AJHG “Year in Review” 2020
The American Journal of Human Genetics has published its Genomic Medicine Year in Review for 2020, an annual feature highlighting ten key advances in applying genomic information to clinical... |
| 01.12.2020 | Congenica Appoints Dr. Muthu Meyyappan as Chief Commercial Officer | Congenica Appoints Dr. Muthu Meyyappan as Chief Commercial Officer
Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, is pleased to announce the appointment of Dr.... |
| 11.11.2020 | Malaysia’s Xeraya Capital invests in Congenica’s $50m Series C funding round | Premium
Malaysia-based private equity firm Xeraya Capital announced on Wednesday its participation in a globally syndicated $50 million Series C investment in Congenica, a UK-headquartered digital health company that claims to provide rapid... |
| 11.11.2020 | Malaysia’s Xeraya Capital invests in Congenica’s $50m Series C funding round | Malaysia-based private equity firm Xeraya Capital announced on Wednesday its participation in a globally syndicated $50 million Series C investment in Congenica, a UK-headquartered digital health company that claims to provide rapid and acc... |
| 09.11.2020 | Congenica completes $50m Series C funding round | Congenica completes $50m Series C funding round to advance clinical genomic analysis software and data platform
New funds to drive further commercialisation of rare and inherited cancer applications and expansion into oncology, wellness and... |
| 09.11.2020 | Congenica completes $50m Series C funding round to advance clinical genomic analysis software and data platform | Congenica completes $50m Series C funding round to advance clinical genomic analysis software and data platform
09-11-2020
Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform peopl... |
| 13.08.2020 | Global Entrepreneur Programme webinar | Global Entrepreneur Programme - Thought Leadership Webinar Panel with CIC's Dr Michael Anstey
Why the UK is an ideal location for Biotech and Healthcare ventures from start-up, scale-up to IPO.
The United Kingdom is a leading global hub for... |
| 24.06.2020 | Putting genomes at the heart of patient care | Putting Genomes at the Heart of Patient Care
A landmark study has been published in Nature reporting how the sequencing and analysis of whole genomes from more than 13,000 patients as part of the UK 100,000 Genomes Project led to the geneti... |
| 03.10.2019 | Congenica integrates powerful new curated data | Congenica integrates powerful new curated data
03-10-2019
Congenica Ltd, a digital health technology company enabling accelerated interpretation of complex genomic data to improve disease diagnosis, has announced significant developments to... |
| 22.07.2019 | Congenica simplifies software branding and enhances platform with CNV calling to deliver genomic medicine globally | Congenica simplifies software branding and enhances platform with CNV calling to deliver genomic medicine globally
22-07-2019
Congenica, a digital health company enabling accelerated genomic data interpretation, today announced it has renam... |
| 01.05.2019 | Daily funding roundup - May 1st, 2019 | Allganize landed $3.4M; Vault Platform closed $4.2M; Pana raised $10M: DivvyCloud secured $20M
Allganize: Allganize provides the best-in-class Natural Language Understanding API and conversational AI for enterprises. Allganize has raised $3... |
| 30.04.2019 | Congenica raises additional £13.25m to reach total of £23.3m for Series B funding round | Congenica, the global clinical decision support platform provider, today announced it has raised a further £13.25 ($17.1) million in additional equity investment, led by Parkwalk Advisors. The round attracted new strategic investors, includ... |
| 30.04.2019 | Congenica raises additional £13.25m to reach total of £23.3m for Series B funding round | Congenica raises additional £13.25m to reach total of £23.3m for Series B funding round
30-04-2019
Congenica, the global clinical decision support platform provider, today announced it has raised a further £13.25 ($17.1) million in addition... |
| 30.04.2019 | The Uncomfortable Truth About Going Public With a Money-Losing Business: Term Sheet for Tuesday, April 30 | TO HELL WITH PROFITABILITY
WeWork (also known as The We Company) is planning to go public. The co-working giant has filed paperwork confidentially with the SEC to conduct an initial public offering in the near future.
Paid Content The enter... |
| 30.04.2019 | Congenica Raises Additional £13.25M in Series B Funding | Congenica, a Cambridge, England, UK-based global clinical decision support platform provider, raised a further £13.25m ($17.1m) in Series B funding.
The total amount raised across its Series B financings is now £23.3m ($30.1m).
The round, w... |
| 01.04.2019 | Congenica announces on-premise deployment option for its Sapientia platform | Congenica, the global diagnostic decision support platform provider, now offers an on-premise deployment method in addition to cloud deployment for running its SapientiaTM platform.
This considerable technical achievement has been completed... |
| 01.02.2018 | Congenica signs strategic digital health contracts during official UK-China Trade Mission | Congenica signs strategic digital health contracts during official UK-China Trade Mission
01-02-2018
Today Congenica, the global provider of clinical genomics interpretation software, signed a series of significant memorandums of understand... |
| 25.01.2018 | Congenica appoints new CEO | Congenica has appointed its new Chief Executive Officer David Atkins, Ph.D. Based at the Company’s headquarters in Cambridge, UK, Dr Atkins also joins Congenica’s Board of Directors.
Dr Atkins has over 25 years’ experience as a global leade... |
| 06.09.2017 | Sapientia selected by Hospital Pediátrico de Coimbra for Portugal’s In2Genome Genetic Disease Diagnosis Project | Congenica has announced a new customer partnership with the Coimbra Paediatric Hospital (CPH), a leading paediatric hospital in Portugal and part of the Coimbra Hospital and University Centre (CHUC). Through this partnership, the hospital h... |
| 22.06.2017 | China’s '100K Wellness Pioneer Project' uses UniteGen and Sapientia™ integrated platform | China’s '100K Wellness Pioneer Project' uses UniteGen and Sapientia™ integrated platform
22-06-2017
Congenica’s Sapientia™ clinical genome analysis software platform will be used by China-based UniteGen to carry out whole genome sequencing ... |
| 27.04.2017 | Completion of Series B for Congenica and Chinese commercial partnership | Congenica has completed its recently announced Series B funding round with additional investments from new strategically important investors BGI Genomics (BGI), a recognized global leader in genomics, Healthlink Capital (Healthlink), anothe... |
| 27.04.2017 | Congenica Completes Series B Financing Round | Congenica, a Cambridge, England, UK-based provider of clinical genomics software for inherited diseases, completed its Series B funding round of undisclosed amount.
Additional investments came from BGI Genomics (BGI), Healthlink Capital (He... |
| 20.04.2017 | Congenica and Edico Genome partnership | Congenica and Edico Genome have partnered to offer their complementary platform technologies as an all-in-one, genome data analysis solution that accelerates clinical labs’ and hospitals’ progression from DNA sequencing to diagnosis for inh... |
| 27.02.2017 | CIC leads Congenica's £8 million funding round | CIC has led a £8 million Series B funding of Congenica, a leading provider of clinical genome analysis technology.
Amadeus Capital Partners (Amadeus) also participated in the round alongside new investor, Parkwalk Advisors (Parkwalk).
Conge... |
| 27.02.2017 | Congenica raises £8M ($10M) in Series B financing round to drive international expansion | Congenica, a leading provider of clinical genome analysis technology, announced today that it has raised £8m ($10m) in its Series B financing round. Existing investors, Cambridge Innovation Capital plc (CIC) and Amadeus Capital Partners par... |
| 27.02.2017 | Congenica Raises £8M in Series B Funding | Congenica, a Cambridge, UK-based provider of clinical genome analysis technology, raised £8m ($10m) in Series B funding.
Backers included existing investors Cambridge Innovation Capital and Amadeus Capital Partners and new investor Parkwalk... |
| 27.02.2017 | Term Sheet — Monday, February 27 | MONEYBALL FOR STARTUPS
Crowdfunding watch: Is it fair to say the realities of equity crowdfunding have not lived up to the category’s promises? Most action in this once-hyped market has been limited to helping same institutional investors a... |
| 27.02.2017 | Congenica raises £8M ($10M) in Series B financing round to drive international expansion | Congenica raises £8M ($10M) in Series B financing round to drive international expansion
27-02-2017
Congenica, a leading provider of clinical genome analysis technology, announced today that it has raised £8m ($10m) in its Series B financin... |
| 18.01.2017 | Congenica expands in North America with strategic appointment | Congenica expands in North America with strategic appointment
18-01-2017
Congenica, a world leading developer of genome analysis and interpretation technologies, expands its operations in the US with the announcement that it has recruited D... |
| 21.11.2016 | Prime Minister opens Congenica's new home in the business incubator building on the Wellcome Genome Campus | The ability to identify disease causing genetic variants offers the potential for improved diagnosis and new treatments. Two organisations at the forefront of this genomics revolution are the first tenants in the new genome sequencing and b... |
| 18.10.2016 | Consistency and data sharing vital to unlock value of genetic testing | Consistency and data sharing vital to unlock value of genetic testing
18-10-2016
“At Congenica we realise that there is huge value in being able to share data to see how others have interpreted the same gene variant,” says Dr Matthew Hurles... |
| 18.10.2016 | Consistency and data sharing vital to unlock value of genetic testing | “At Congenica we realise that there is huge value in being able to share data to see how others have interpreted the same gene variant,” says Dr Matthew Hurles, co-founder of Congenica, a world leader in genomic analysis and interpretation.... |
| 10.10.2016 | OBN awards Congenica 'Best implementation of digital healthcare’ | OBN awards Congenica 'Best implementation of digital healthcare’
10-10-2016
Congenica was given the accolade of ‘Best Implementation of Digital Healthcare’ in the OBN awards. Congenica has introduced its Sapientia platform into the NHS - on... |
| 07.10.2016 | Congenica wins OBN award | Congenica was given the accolade of ‘Best Implementation of Digital Healthcare’ for introducing its SapientiaTMplatform into one of the most highly regulated healthcare systems in the world in just two years.
SapientiaTM, the digital platfo... |
| 20.09.2016 | Companies need 'someone with a vision and the right team to make it work' | Companies need 'someone with a vision and the right team to make it work'
20-09-2016
Dr Tom Weaver, CEO of Congenica, shares the secrets of success at the Innovation Forum 2016 - Leaders Conference in Cambridge tomorrow (21 September).
Entr... |
| 26.08.2016 | Congenica first UK company to deliver diagnostic reports to 100,000 Genomes Project | Congenica, a clinical interpretation partner for the 100,000 Genomes Project, has announced the successful delivery of diagnostic reports to the NHS Genomic Medicine Centres.
Genomics England has been working closely with three companies ov... |
| 24.08.2016 | Is the virtual gene panel the way forward, asks Congenica at Dx Summit | Is the virtual gene panel the way forward, asks Congenica at Dx Summit
24-08-2016
Mike Furness of Cambridge-based genomics analysis company Congenica says more clinical input is required to ensure consistency.
Although the current practice ... |
| 11.05.2016 | Congenica takes Birmingham Women's Hospital to the forefront of genomic diagnosis | Congenica takes Birmingham Women's Hospital to the forefront of genomic diagnosis
11-05-2016
Birmingham Women's Hospital adopts Congenica’s Sapientia for gene-disease insights that reclassify disease.
Birmingham Women's Hospital (BWH) is th... |
| 11.05.2016 | Congenica takes Birmingham Women's Hospital to the forefront of genomic diagnosis | Birmingham Women's Hospital adopts Congenica’s Sapientia for gene-disease insights that reclassify disease.
Birmingham Women's Hospital (BWH) is the latest NHS hospital to adopt Congenica's Sapientia™ technology, which makes it easier to id... |
| 08.03.2016 | Tri-Con 2016 marks new era of genomic medicine, says Congenica | Tri-Con 2016 marks new era of genomic medicine, says Congenica
08-03-2016
Mike Furness of Congenica says that Molecular Medicine Tri-Con 2016 comes at an exciting time for the industry.
The company has been in discussion with many organisat... |
| 07.03.2016 | Rare disease or rare success: a tale of two genomes | Rare disease or rare success: a tale of two genomes
07-03-2016
Congenica is to help a woman who self-diagnosed the genetic cause of both her muscle-wasting disease and an Olympic athlete’s extreme muscular physique.
When Congenica heard how... |
| 29.02.2016 | Rare Disease Day focuses on new approach to finding treatment | Rare Disease Day focuses on new approach to finding treatment
29-02-2016
Findacure says it could save the NHS millions of pounds, based on US experience.
Two thousand two hundred babies will be born in the UK today (29th February), of which... |
| 18.12.2015 | UCB works with Congenica to support rare disease genomic research | UCB works with Congenica to support rare disease genomic research
18-12-2015
As a leader in genomic interpretation, Congenica is excited to begin working with UCB, enabling researchers to bridge genomics and drug development and bring much ... |
| 05.11.2015 | Congenica and GenomOncology announce collaborative agreement | Congenica and GenomOncology announce collaborative agreement
05-11-2015
Congenica, leader in genomic interpretation and diagnostics in rare genetic disease, and GenomOncology, specialists in precision medicine technology in the field of onc... |
| 15.10.2015 | Unique collaboration between NHSA and Congenica announced at BIA Bioscience Forum | Unique collaboration between NHSA and Congenica announced at BIA Bioscience Forum
15-10-2015
Rare disease diagnosis will be available in days, not years, as a new agreement paves the way for a consistent diagnostic platform across the North... |
| 01.10.2015 | Genomics England announces Congenica as an interpretation partner | Genomics England announces Congenica as an interpretation partner
01-10-2015
Genomics England announces that Congenica has won a contract to provide genome interpretation for 8000 patients participating in the 100,000 Genomes Project.
Tom W... |
| 08.06.2015 | Faster, more accurate diagnosis for genetic disease reaches patients | Faster, more accurate diagnosis for genetic disease reaches patients
08-06-2015
Manchester Centre for Genomic Medicine becomes the first NHS genetics service in the country to use genome DNA sequence analysis supported by Sapientia, a techn... |
| 14.04.2015 | Genome diagnostic company Congenica raises £2.2m | Genome diagnostic company Congenica raises £2.2m
14-04-2015
Cambridge-based Congenica, a spinout from The Wellcome Trust Sanger Institute, has raised a further £2.2m with the completion of a series A round of financing by Amadeus Capital Pa... |
| 14.04.2015 | Congenica, genome diagnostics company, raises £2.2m | Congenica, genome diagnostics company, raises £2.2m |
| 11.03.2015 | Diagnosis of rare genetic diseases receives a boost as Congenica gains £2m Genomics England SBRI award to fast-track technology for gene-disease interpretation | Diagnosis of rare genetic diseases receives a boost as Congenica gains £2m Genomics England SBRI award to fast-track technology for gene-disease interpretation |
| 11.03.2015 | Diagnosis of rare genetic diseases boosted as Congenica gains £2m Genomics England SBRI | Diagnosis of rare genetic diseases boosted as Congenica gains £2m Genomics England SBRI
11-03-2015
Currently many children with rare genetic disorders caused by single gene mutations do not have a specific diagnosis. To help address this is... |
| - | Parkwalk – continues impressive investment rate | Parkwalk has invested over £60 million into university spin-outs so far in 2019. |
| - | The time to put the spotlight on Healthcare is now | As Covid-19 continues to dominate the global agenda, early-stage UK technology companies in the healthcare and life sciences sectors are at the forefront of making the world a safer and more secure place to live in.
The need for accelera... |
| - | Congenica’s £39M Series C funding: QVentures invests in Britain’s fastest-growing genomics startup | London-based venture capital firm, QVentures announces to have backed Britain’s fastest-growing genomics company, Congenica’s Series C round of funding. QVenture’s investment follows an initial round of investment in November 2020.
In the m... |
| - | Congenica – Congenica Raises £23.3M ($30.1M) for Series B Funding Round | Congenica, the global clinical decision support platform provider, today announced it has raised a further £13.25 ($17.1) million in additional equity investment, led by Parkwalk Advisors. The round attracted new strategic investors, includ... |
| - | Downing Ventures Participates in $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform | Downing Ventures is delighted to announce its participation in the Series C funding round in Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives. Downing Ventures we... |
| - | Congenica – earns major role in supporting world’s first routine national genomic medicine service | Cambridge, United Kingdom – 17 October, 2018 – Congenica has been awarded a multi-year contract by Genomics England, to be a provider of Diagnostic Decision Support Services for them to deliver for the world leading NHS Genomic Medicine Ser... |
| - | Congenica – $50m Series C Funding Round | Parkwalk are delighted to continue to support and back Congenica in their latest funding round. This $50m series C investment will advance the company’s clinical genomic analysis software and data platform. As the largest shareholder in Con... |
| - | Parkwalk H1 2017 update | It has been a busy first half of the year at Parkwalk. Our proprietary access to deal-flow has enabled us to deploy £46.5m in the last 12 months. Deal-flow has been enhanced by our tie-up with IP Group plc, who recently raised a further £20... |
| - | EIS: more than financial returns | As institutional investors increasingly regard ESG as an important element of their investment decision, Tom Hopkins, of Parkwalk, wonders whether this element of EIS investment should form part of the client conversation. |
| - | Parkwalk – Q3 update | Welcome to the third quarterly update of 2020, a year that has certainly been a roller-coaster to say the least! |
